These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 25252843
1. Correction of metabolic acidosis in hemodialysis: consequences on serum leptin and mineral metabolism. Bales AM, Moysés RM, dos Reis LM, Graciolli FG, Hung J, Martins Castro MC, Elias RM. Int Urol Nephrol; 2015 Jan; 47(1):177-82. PubMed ID: 25252843 [Abstract] [Full Text] [Related]
2. Correction of metabolic acidosis and its effect on albumin in chronic hemodialysis patients. Brady JP, Hasbargen JA. Am J Kidney Dis; 1998 Jan; 31(1):35-40. PubMed ID: 9428449 [Abstract] [Full Text] [Related]
3. Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study. Movilli E, Zani R, Carli O, Sangalli L, Pola A, Camerini C, Scolari F, Cancarini GC, Maiorca R. Nephron; 2001 Mar; 87(3):257-62. PubMed ID: 11287761 [Abstract] [Full Text] [Related]
4. Long-term management of sevelamer hydrochloride-induced metabolic acidosis aggravation and hyperkalemia in hemodialysis patients. Sonikian M, Metaxaki P, Iliopoulos A, Marioli S, Vlassopoulos D. Ren Fail; 2006 Mar; 28(5):411-8. PubMed ID: 16825091 [Abstract] [Full Text] [Related]
5. Effect of CAPD and hemodialysis on parathyroid function. Malberti F, Corradi B, Imbasciati E. Adv Perit Dial; 1996 Mar; 12():239-44. PubMed ID: 8865912 [Abstract] [Full Text] [Related]
6. Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients. Movilli E, Viola BF, Camerini C, Mazzola G, Cancarini GC. J Ren Nutr; 2009 Mar; 19(2):172-7. PubMed ID: 19218045 [Abstract] [Full Text] [Related]
7. Acute correction of metabolic acidosis increases serum procollagen type I carboxyterminal propeptide in patients with chronic renal failure. Chu P, Lu KC, Lin YF. J Formos Med Assoc; 2001 Nov; 100(11):748-52. PubMed ID: 11802533 [Abstract] [Full Text] [Related]
8. Effect of dialysate calcium concentrations on parathyroid hormone and calcium balance during a single dialysis session using bicarbonate hemodialysis: a crossover clinical trial. Basile C, Libutti P, Di Turo AL, Vernaglione L, Casucci F, Losurdo N, Teutonico A, Lomonte C. Am J Kidney Dis; 2012 Jan; 59(1):92-101. PubMed ID: 22000728 [Abstract] [Full Text] [Related]
9. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure. Lu KC, Lin SH, Yu FC, Chyr SH, Shieh SD. Miner Electrolyte Metab; 1995 Jan; 21(6):398-402. PubMed ID: 8592483 [Abstract] [Full Text] [Related]
10. Interrelationship between plasma leptin concentration and severity of metabolic acidosis in haemodialysed patients with chronical renal failure. Kokot F, Chudek J, Adamczak M, Wieçek A. Exp Clin Endocrinol Diabetes; 2001 Jan; 109(7):370-3. PubMed ID: 11573148 [Abstract] [Full Text] [Related]
11. Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L. Yamada S, Ueki K, Tokumoto M, Suehiro T, Kimura H, Taniguchi M, Fujimi S, Kitazono T, Tsuruya K. Ther Apher Dial; 2016 Feb; 20(1):31-9. PubMed ID: 26482334 [Abstract] [Full Text] [Related]
12. Dialysis modality and correction of uremic metabolic acidosis: relationship with all-cause and cause-specific mortality. Vashistha T, Kalantar-Zadeh K, Molnar MZ, Torlén K, Mehrotra R. Clin J Am Soc Nephrol; 2013 Feb; 8(2):254-64. PubMed ID: 23184567 [Abstract] [Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
14. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Elsharkawy MM, Youssef AM, Zayoon MY. Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745 [Abstract] [Full Text] [Related]
15. Parathyroid hormone during maintenance dialysis: influence of low calcium dialysate, plasma albumin and age. Heaf JG, Løkkegård H. J Nephrol; 1998 Oct; 11(4):203-10. PubMed ID: 9702872 [Abstract] [Full Text] [Related]
16. Relationship between serum leptin levels and bone mineral density and bone metabolic markers in patients on hemodialysis. Ahmadi F, Salari S, Maziar S, Esfahanian F, Khazaeipour Z, Ranjbarnovin N. Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):41-7. PubMed ID: 23354190 [Abstract] [Full Text] [Related]
17. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism]. Matuszkiewicz-Rowińska J, Niemczyk S, Przedlacki J, Puka J, Switalski M, Ostrowski K. Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839 [Abstract] [Full Text] [Related]
18. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group. Weinreich T, Ritz E, Passlick-Deetjen J. Perit Dial Int; 1996 Jul; 16(3):260-8. PubMed ID: 8761540 [Abstract] [Full Text] [Related]
19. Calcium exposure and removal in chronic hemodialysis patients. Sigrist M, McIntyre CW. J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440 [Abstract] [Full Text] [Related]
20. Metabolic acidosis in peritoneal dialysis patients: the role of residual renal function. Tian XK, Shan YS, Zhe XW, Cheng LT, Wang T. Blood Purif; 2005 Jan; 23(6):459-65. PubMed ID: 16244471 [Abstract] [Full Text] [Related] Page: [Next] [New Search]